Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-07-22 00:00:00 ET · period of report 2025-07-18 · accession 0000950170-25-097601 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-22 | 2025-07-18 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.72 | +33.4K | 383.6K | +10% | +$24.1K |
| D | 2025-07-22 | 2025-07-18 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.00 | -33.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-18 | M | A | 33,437 | $0.72 | 383,621 | D | — | — | (F2) Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order. (F1) Includes 325,098 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-07-18 | M | D | 33,437 | $0.00 | 0 | D | $0.72 · 2019-07-28 to 2025-07-28 | 33,437 Common Stock | (F3) The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019. |